Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003479619 | SCV004223106 | uncertain significance | not specified | 2023-11-22 | criteria provided, single submitter | clinical testing | Variant summary: CACNA1A c.*418G>A is located in the untranslated mRNA region downstream of the termination codon. The variant allele was found at a frequency of 5.3e-06 in 1326160 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.*418G>A in individuals affected with Early Infantile Epileptic Encephalopathy or Episodic Ataxia and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. |